Marksans Pharma shines on inking settlement agreement with Bond holders

22 Jun 2015 Evaluate

Marksans Pharma is currently trading at Rs. 60.40, up by 1.65 points or 2.81% from its previous closing of Rs. 58.75 on the BSE.

The scrip opened at Rs. 58.50 and has touched a high and low of Rs. 62.40 and Rs. 56.80 respectively. So far 581546 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 75.00 on 15-Apr-2015 and a 52 week low of Rs. 26.05 on 11-Jul-2014.

Last one week high and low of the scrip stood at Rs. 62.40 and Rs. 56.20 respectively. The current market cap of the company is Rs. 2468.16 crore.

The promoters holding in the company stood at 48.25% while Institutions and Non-Institutions held 14.47% and 37.28% respectively.

Marksans Pharma has signed settlement agreement with few Bond holders for settlement of the then outstanding 36,789 Bonds of $1,000 each in principal value. Out of that, 21,511 Bonds have already been settled and cancelled. However, one bond holder holding 15,278 Bonds defaulted in surrendering the third and final tranche Bonds as per the settlement agreement signed with the Company even though the Company was ready to pay the settlement consideration.

The bond holder has already executed and surrendered first and second tranche Bonds which were subsequently cancelled and extinguished but defaulted in executing the third and final tranche Bonds. The Company had filed a suit in the High Court of England seeking specific performance by the Bond holder in accordance with the settlement agreement and got injunction restraining the Bond holder from selling or transferring their bonds to a third party.

The High Court of England has disposed off the said suit in favour of the Company and passed order for specific performance by the bond holder in accordance with the settlement agreement. Consequently, after execution of the 15,278 Bonds settlement, only 61 Bonds of USD 1,000 each in principal value (out of the total issued 50,000 Bonds) will remain outstanding as the same are untraceable which have been adequately accounted for in the books of account.

Marksans Pharma is engaged in production of prescription drugs, caters in areas like oncology, gastroenterology, antidiabetic, cardiovascular, pain management, gynaecology and others.

 

Marksans Pharma Share Price

183.95 -3.95 (-2.10%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×